DR. ABRAM TREVINO MD NPI 1346323888

NPI Information

  • NPI: 1346323888
  • Provider Name: DR. ABRAM TREVINO, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1448 COMMON ST
    NEW BRAUNFELS, TX
    ZIP 78130
  • Phone: (830) 643-1762

Map and Directions

Get Directions

NPI Details

DR. Abram Trevino, MD is a medical oncology internal medicine in New Braunfels, TX with 23 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Abram Trevino, MD NPI is 1346323888. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Graduation Year:2003

The provider's business location address is:

1448 COMMON ST
NEW BRAUNFELS, TX
ZIP 78130-162
Phone: (830) 643-1762
Fax: (830) 609-7702

The NPI 1346323888 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev (HCPCS:G6013)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Folic acid level, serum (HCPCS:82746)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Unclassified drugs (HCPCS:J3490)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection of drug or substance into vein (HCPCS:96374)

The enumeration date for this NPI number is 10/20/2006 and was last updated on 1/28/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineMD-13859HAWAIINo
2207RX0202XInternal MedicineMedical OncologyM4602TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1213500603MEDICAIDTEXAS
2TXB102861MEDICARE PINTEXAS
3213500601MEDICAIDTEXAS
4P01547718OTHERTEXASRAIROAD MEDICARE
5442749YKYCMEDICARE PINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.